{reportSlug=global-non-alcoholic-steatohepatitis-market, reportId=34672, mktKeyword=Non-alcoholic Steatohepatitis, cagr=0.00, publishDate=Jan 2024, priceOption2=6500, reportTitle=Non-alcoholic Steatohepatitis Comprehensive Study by Type (Ocaliva, Elafibranor, Selonsertib, Cenicriviroc, Others), Application (Hypertension, Heart Disease, High Blood Lipid, Diabetes, Obesity), End Use Verticals (Pharma & CRO Industry, Hospitals, Diagnostic Labs, Academic Research Institutes) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=200, priceOption1=3450, forecastYr=2030, noOfPages=239, reportKey=34406, breadcrum=Global Non-alcoholic Steatohepatitis}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Jan 2024 239 Pages 66 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales
AMA Research - Asia Pacific Client Engagement Partner

Filza Sayed

APAC Client Engagement Partner